C Barnett
Overview
Explore the profile of C Barnett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
460
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Atlas H, Safa N, Denis R, Garneau P, Marceau S, Lebel S, et al.
Can J Surg
. 2022 Apr;
53(4):S51-S104.
PMID: 35488396
No abstract available.
2.
Hamoy-Jimenez G, Elahmar H, Mendoza M, Kim R, Bril V, Barnett C
Orphanet J Rare Dis
. 2022 Feb;
17(1):40.
PMID: 35135568
Background: There is limited data regarding gender differences in quality of life between women and men with Neurofibromatosis type 1. We aimed to study differences in quality of life domains...
3.
Alcantara M, Sarpong E, Barnett C, Katzberg H, Bril V
Eur J Neurol
. 2020 Sep;
28(2):639-646.
PMID: 32964565
Background And Purpose: Long-term treatment of myasthenia gravis (MG) includes symptomatic and course-modifying therapies that target the immune system. Recently, both intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) have emerged...
4.
Menon D, Barnett C, Bril V
Eur J Neurol
. 2020 Jun;
27(11):2286-2291.
PMID: 32537828
Background And Purpose: The single simple question (SSQ) is a simple and validated question asking what percentage of normal a patient feels with respect to their myasthenia gravis (MG), with...
5.
Kassardjian C, Widdifield J, Paterson J, Kopp A, Nagamuthu C, Barnett C, et al.
Eur J Neurol
. 2020 Jan;
27(4):702-708.
PMID: 31997519
Background And Purpose: To characterize the frequency and risk of serious infections in patients with myasthenia gravis (MG) relative to age/sex/area-matched comparators. Methods: This was a population-based cohort study in...
6.
Bogdan A, Barnett C, Ali A, AlQwaifly M, ABraham A, Mannan S, et al.
Eur J Neurol
. 2019 Aug;
27(1):204-209.
PMID: 31408565
Background And Purpose: Stress is a known risk factor for the onset and modulation of disease activity in autoimmune disorders. The aim of this cross-sectional study was to determine any...
7.
Barnett C, Bril V, Bayoumi A
Eur J Neurol
. 2018 Oct;
26(3):452-459.
PMID: 30315714
Background And Purpose: Health utilities are a preference-based method of valuing health states that are used in healthcare research, such as economic evaluations. There are limited health utility valuation data...
8.
Idiaquez J, Gonzalez S, Lasso-Penafiel J, Barnett C
Rev Neurol
. 2017 Dec;
66(1):15-20.
PMID: 29251338
Introduction: Medication adherence is a public health problem and this has not been previously studied in myasthenia gravis patients. Aim: To determine if patients with myasthenia gravis are adherent to...
9.
ABraham A, Barnett C, Katzberg H, Lovblom L, Perkins B, Bril V
Eur J Neurol
. 2017 Dec;
25(3):484-490.
PMID: 29194856
Background And Purpose: The Toronto Clinical Neuropathy Score (TCNS) is a valid and reliable scale for the diagnosis and staging of diabetic sensorimotor polyneuropathy. In this study, we aimed to...
10.
Kassardjian C, Kokokyi S, Barnett C, Jewell D, Bril V, Murray B, et al.
J Neuromuscul Dis
. 2017 Feb;
2(1):93-97.
PMID: 28198710
Excessive daytime sleepiness (EDS) has not been investigated using objective tests in myasthenia gravis (MG). We investigated whether objective measurements of somnolence better detected abnormalities compared with sleepiness questionnaires in...